Healthcare provider profile · identity verified

Nathan Bernard Mitkoff, M.D.

Internal Medicine · ALBANY, NY · NPI 1740274604

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	371	109
Omeprazole	Omeprazole	298	91
Gabapentin	Gabapentin	193	43
Amlodipine Besylate	Amlodipine Besylate	191	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	183	26
Zolpidem Tartrate	Zolpidem Tartrate	178	28
Pantoprazole Sodium	Pantoprazole Sodium	162	44
Lisinopril	Lisinopril	148	41
Metoprolol Succinate	Metoprolol Succinate	144	39
Levothyroxine Sodium	Levothyroxine Sodium	141	40
Losartan Potassium	Losartan Potassium	141	38
Metformin Hcl	Metformin Hcl	120	29
Simvastatin	Simvastatin	120	29
Albuterol Sulfate Hfa	Albuterol Sulfate	117	31
Tamsulosin Hcl	Tamsulosin Hcl	114	28
Famotidine	Famotidine	102	35
Bupropion Xl	Bupropion Hcl	87	29
Duloxetine Hcl	Duloxetine Hcl	87	22
Pravastatin Sodium	Pravastatin Sodium	84	23
Celecoxib	Celecoxib	83	21
Metformin Hcl Er	Metformin Hcl	83	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	81	suppressed
Trazodone Hcl	Trazodone Hcl	80	20
Rosuvastatin Calcium	Rosuvastatin Calcium	77	22
Hydrochlorothiazide	Hydrochlorothiazide	74	25
Fluticasone Propionate	Fluticasone Propionate	69	26
Allopurinol	Allopurinol	68	17
Montelukast Sodium	Montelukast Sodium	67	18
Escitalopram Oxalate	Escitalopram Oxalate	64	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	18
Venlafaxine Hcl Er	Venlafaxine Hcl	60	16
Clonazepam	Clonazepam	59	13
Oxycodone Hcl	Oxycodone Hcl	59	14
Sertraline Hcl	Sertraline Hcl	59	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	58	18
Eliquis	Apixaban	57	suppressed
Jardiance	Empagliflozin	57	15
Methadone Hcl	Methadone Hcl	54	suppressed
Ozempic	Semaglutide	47	suppressed
Pregabalin	Pregabalin	47	suppressed
Buspirone Hcl	Buspirone Hcl	45	suppressed
Tizanidine Hcl	Tizanidine Hcl	43	12
Irbesartan	Irbesartan	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	12
Tramadol Hcl	Tramadol Hcl	41	suppressed
Diazepam	Diazepam	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Alendronate Sodium	Alendronate Sodium	39	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Alprazolam	Alprazolam	36	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	36	suppressed
Fentanyl	Fentanyl	36	suppressed
Potassium Chloride	Potassium Chloride	33	12
Trulicity	Dulaglutide	33	suppressed
Morphine Sulfate Er	Morphine Sulfate	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Furosemide	Furosemide	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Rybelsus	Semaglutide	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	11
Valacyclovir	Valacyclovir Hcl	28	12
Olanzapine	Olanzapine	27	suppressed
Lorazepam	Lorazepam	26	11
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Baclofen	Baclofen	25	suppressed
Finasteride	Finasteride	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Amoxicillin	Amoxicillin	22	suppressed
Carvedilol	Carvedilol	22	suppressed
Colchicine	Colchicine	22	suppressed
Risperidone	Risperidone	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Oxycontin	Oxycodone Hcl	20	suppressed
Primidone	Primidone	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Prednisone	Prednisone	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Torsemide	Torsemide	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Valsartan	Valsartan	16	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Tramadol Hcl Er	Tramadol Hcl	15	suppressed
Myrbetriq	Mirabegron	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Topiramate	Topiramate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Modafinil	Modafinil	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error